365
Views
12
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Analysis of the downstream mediators of toll-like receptor 3-induced apoptosis in labial salivary glands in patients with Sjögren's syndrome

, , , &
Pages 99-104 | Received 10 Dec 2014, Accepted 20 Apr 2015, Published online: 28 May 2015

References

  • Moutsopoulos HM, Chused TM, Mann DL, Klippel JH, Fauci AS, Frank MM, et al. Sjögren's syndrome (Sicca syndrome): Current issues. Ann Intern Med. 1980;92(2 Pt 1):212–26.
  • Terada K, Katamine S, Eguchi K, Moriuchi R, Kita M, Shimada H, et al. Prevalence of serum and salivary antibodies to HTLV-1 in Sjögren's syndrome. Lancet. 1994;344(8930):1116–9.
  • Kawakami A, Nakashima K, Tamai M, Nakamura H, Iwanaga N, Fujikawa K, et al. Toll-like receptor in salivary glands from patients with Sjögren's syndrome: Functional analysis by human salivary gland cell line. J Rheumatol. 2007;34(5):1019–26.
  • Vercammen E, Staal J, Beyaert R. Sensing of viral infection and activation of innate immunity by toll-like receptor 3. Clin Microbiol Rev. 2008;21(1):13–25.
  • Lai Y, Yi G, Chen A, Bhardwaj K, Tragesser BJ, Valverde RA, et al. Viral double-strand RNA-binding proteins can enhance innate immune signaling by toll-like Receptor 3. PLOS ONE. 2011;6:e25837.
  • Nakamura H, Horai Y, Suzuki T, Okada A, Ichinose K, Yamasaki S, et al. TLR3-mediated apoptosis and activation of phosphorylated Akt in the salivary gland epithelial cells of primary Sjögren's syndrome patients. Rheumatol Int. 2013;33(2):441–50.
  • Nakamura H, Kawakami A, Ida H, Koji T, Eguchi K. EGF activates PI3K-Akt and NF-kappaB via distinct pathways in salivary epithelial cells in Sjögren's syndrome. Rheumatol Int. 2007;28(2):127–36.
  • Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554–8.
  • Nakamura H, Kawakami A, Iwamoto N, Ida H, Koji T, Eguchi K. Rapid and significant induction of TRAIL-mediated type II cells in apoptosis of primary salivary epithelial cells in primary Sjögren's syndrome. Apoptosis. 2008;13(11):1322–30.
  • Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by toll-like receptor 3. Nature. 2001;413(6857):732–8.
  • Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T. TLR3 can directly trigger apoptosis in human cancer cells. J Immunol. 2006;176(8):4894–901.
  • Khvalevsky E, Rivkin L, Rachmilewitz J, Galun E, Giladi H. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis. J Cell Biochem. 2007;100(5):1301–12.
  • Mitsias DI, Kapsogeorgou EK, Moutsopoulos HM. The role of epithelial cells in the initiation and perpetuation of autoimmune lesions: Lessons from Sjögren's syndrome (autoimmune epithelitis). Lupus. 2006;15(5):255–61.
  • Turkseven S, Drummond G, Rezzani R, Rodella L, Quan S, Ikehara S, Abraham NG. Impact of silencing HO-2 on EC-SOD and the mitochondrial signaling pathway. J Cell Biochem. 2007;100(4): 815–23.
  • Son TW, Yun SP, Yong MS, Seo BN, Ryu JM, Youn HY, et al. Netrin-1 protects hypoxia-induced mitochondrial apoptosis through HSP27 expression via DCC- and integrin α6β4-dependent Akt, GSK-3β, and HSF-1 in mesenchymal stem cells. Cell Death Dis. 2013; 4(3):e563.
  • Saito I, Shimuta M, Terauchi K, Tsubota K, Yodoi J, Miyasaka N. Increased expression of human thioredoxin/adult T cell leukemia-derived factor in Sjögren's syndrome. Arthritis Rheum. 1996; 39(5):773–82.
  • Franceschini F, Cavazzana I. Anti-Ro/SSA and La/SSB antibodies. Autoimmunity. 2005;38(1):55–63.
  • Rader MD, O’Brien C, Liu YS, Harley JB, Reichlin M. Heterogeneity of the Ro/SSA antigen. Different molecular forms in lymphocytes and red blood cells. J Clin Invest. 1989;83(4):1293–8.
  • Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16(1):3–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.